John, I've had a look at the new NHS libre guidelines, click on the pdf link in this link:
https://www.england.nhs.uk/publicat...ts-for-funding-of-relevant-diabetes-patients/
While it's aimed at T1s, note at page 3 of the PDF, the criterion also address "diabetes associated with cystic fibrosis on insulin treatment."
That's a non-typical type of diabetes. I was vaguely aware of it through following Partha Kar's tweets but didn't know what it was till I googled it, for example:
https://www.cff.org/Life-With-CF/Daily-Life/Cystic-Fibrosis-Related-Diabetes/
CF diabetes isn't T1 or T2. I've not been following the politics of it closely enough to say why CF diabetes ended up included on the list, but I suspect there was a lot of politicking going on, and Partha Kar was heavily supportive of it.
Here's his twitter stuff:
https://mobile.twitter.com/parthaskar?ref_src=twsrc^google|twcamp^serp|twgr^author
Because CF diabetes, which is not T1, is now in the guidelines, I wonder whether there is scope for the relatively rare T3c/e peeps to push their case too if insulin shots are involved.
How you do that, I don't know, (is there a T3 advocacy group?) but I can tell you that when Partha (as national lead on T1)was involved in writing/negotiating/wrangling the guidelines, he said that not everyone was going to be happy with them, but, operating within the limits of NHS politics, they were do-able and a good starting point for expected loosening up as time went by.
These rules are going to loosen up and I think there is plenty of scope there for non-typical types of diabetes making their case if there's a big hypo risk.